Scholarly Index
Dongrui R. Lu
Pfizer (United States); 9,601 total citations; 88 total publications; best world rank #152
Pfizer (United States)
9,601Total citations
88Total publications
30H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Advanced Breast Cancer Therapies | Lifetime | 933 | US 386 | 92.82 |
| Advanced Breast Cancer Therapies | 2021-2025 | 936 | US 321 | 83.85 |
| Cancer-related Molecular Pathways | 2021-2025 | 774 | US 242 | 74.80 |
| 14-3-3 protein interactions | 2021-2025 | 152 | US 39 | 50.14 |